Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Induces Dry Skin via Decreased in Aquaporin-3 Expression

An adverse reaction of dry skin occurs frequently during treatment with anticancer epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). In this study, we conducted basic research to clarify the mechanism of EGFR-TKI-induced dry skin and propose new treatments or preventative meas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomolecules
Asıl Yazarlar: Ikarashi, Nobutomo, Kaneko, Miho, Watanabe, Tomofumi, Kon, Risako, Yoshino, Makana, Yokoyama, Takatoshi, Tanaka, Riho, Takayama, Naoya, Sakai, Hiroyasu, Kamei, Junzo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225942/
https://ncbi.nlm.nih.gov/pubmed/32260143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10040545
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller